Global X Management Co. LLC Has $192.73 Million Position in Albemarle Co. (ALB)
Global X Management Co. LLC increased its position in Albemarle Co. (NYSE:ALB) by 497.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,506,961 shares of the specialty chemicals company’s stock after acquiring an additional 1,254,927 shares during the quarter. Albemarle comprises 4.4% of Global X Management Co. LLC’s investment portfolio, making the stock its largest holding. Global X Management Co. LLC’s holdings in Albemarle were worth $192,725,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Thompson Davis & CO. Inc. increased its holdings in Albemarle by 650.0% in the 3rd quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 650 shares during the last quarter. SeaCrest Wealth Management LLC purchased a new position in Albemarle during the 4th quarter valued at about $103,000. Stephens Inc. AR purchased a new position in Albemarle during the 4th quarter valued at about $115,000. Advisory Services Network LLC grew its holdings in Albemarle by 43.7% during the 2nd quarter. Advisory Services Network LLC now owns 1,273 shares of the specialty chemicals company’s stock valued at $134,000 after buying an additional 387 shares in the last quarter. Finally, Howe & Rusling Inc. grew its holdings in Albemarle by 2,038.0% during the 3rd quarter. Howe & Rusling Inc. now owns 1,069 shares of the specialty chemicals company’s stock valued at $146,000 after buying an additional 1,019 shares in the last quarter. 87.38% of the stock is owned by institutional investors.
ALB has been the subject of a number of recent analyst reports. Robert W. Baird reaffirmed a “hold” rating and set a $135.00 target price on shares of Albemarle in a report on Wednesday, November 1st. UBS Group raised Albemarle from a “neutral” rating to a “buy” rating and lifted their target price for the company from $113.00 to $150.00 in a report on Tuesday, January 30th. Jefferies Group lifted their target price on Albemarle from $156.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, November 14th. Oppenheimer reaffirmed a “buy” rating on shares of Albemarle in a report on Wednesday, January 17th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and set a $149.00 target price on shares of Albemarle in a report on Wednesday, October 18th. Ten analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $127.88.
Albemarle Company Profile
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.